Vertex Pharmaceuticals Inc (VRTX)
440.62
+1.97
(+0.45%)
USD |
NASDAQ |
May 19, 16:00
Vertex Pharmaceuticals Free Cash Flow: -1.258B for March 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences Inc | 9.844B |
| Eli Lilly and Co | -1.270B |
| Amgen Inc | 10.92B |
| Moderna Inc | -4.034B |
| Regeneron Pharmaceuticals Inc | 2.962B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 818.90M |
| Cash from Investing (Quarterly) | -55.80M |
| Cash from Financing (Quarterly) | -680.40M |
| Free Cash Flow Per Share (Quarterly) | 2.999 |
| Free Cash Flow to Equity (Quarterly) | 778.20M |
| Free Cash Flow to Firm (Quarterly) | 778.20M |
| Free Cash Flow Yield | -1.10% |